About PD Theranostics
PD Theranostics is a private company based in New York, New York, incorporated in 2019 in Delaware. It has reported $508,165 raised in two offerings on Form D since December 2023. Its chief executive is Patrick Gallagher.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 12, 2022 | Dec 14, 2023 | $150,000of $1.0M target | 2 | $75,000 | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Jul 12, 2022 | Jul 28, 2022amended Jul 28, 2022 | $358,165of $5.9M target | 3 | $119K | Equity, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $508,165 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on PD Theranostics's Form D filed Dec 14, 2023.
ME
PG
Patrick Gallagher
Chief Executive Officer and director
Also a director at Aerwave Medical and Algorithm Sciences and a chief executive officer and director at Voltron Therapeutics.
JA
MD
Matthew Duffy
President, Treasurer, Secretary and director
Also a director at Aerwave Medical and Algorithm Sciences and a president and director at Voltron Therapeutics.